Industry Research Reports
Home > Reports > Service & Software > Global Lung Cancer Screening Software Market Research Report 2026
Global Lung Cancer Screening Software Market Research Report 2026
Industry: Service & Software
Published Date: 2026-01-14
Pages: 115 Pages
Report ld: 5649947
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Lung Cancer Screening Software Market Size(US$)
CAGR 2026-2032
18.0%
Market Size,2032
USD 5,434
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,013 million
Market Forecast in 2032(Value)
US$ 5,434 million
CAGR
18.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an "auxiliary tool" to a "key node in the screening process."
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
This report delivers a comprehensive overview of the global Lung Cancer Screening Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lung Cancer Screening Software. The Lung Cancer Screening Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lung Cancer Screening Software market comprehensively. Regional market sizes by Type, by Application, by Screening Technologies, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lung Cancer Screening Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- InferVision
- Airdoc
- VUNO
- Lunit
- Qure.ai
- Riverain Technologies
- Zebra Medical Vision
- Arterys
- Deepwise
- EverFortune AI
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cloud-Based
- Web-Based
Segment by Application
- Hospitals
- Medical Examination Institutions
- Public Health Screening
- Others
Segment by Category
- Nodule Detection
- Nodule Analysis
- Full-Process Screening
- Predictive Assessment
Segment by Division
- Standalone AI Software
- PACS/RIS Integrated Plugin
- Built-in Solution for Imaging Equipment
- Regional Screening Platform System
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Screening Technologies, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lung Cancer Screening Software companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Screening Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cloud-Based
1.2.3 Web-Based
1.3 Market by Screening Technologies
1.3.1 Global Lung Cancer Screening Software Market Size Growth Rate by Screening Technologies: 2021 vs 2025 vs 2032
1.3.2 Nodule Detection
1.3.3 Nodule Analysis
1.3.4 Full-Process Screening
1.3.5 Predictive Assessment
1.4 Market by System Integration Level
1.4.1 Global Lung Cancer Screening Software Market Size Growth Rate by System Integration Level: 2021 vs 2025 vs 2032
1.4.2 Standalone AI Software
1.4.3 PACS/RIS Integrated Plugin
1.4.4 Built-in Solution for Imaging Equipment
1.4.5 Regional Screening Platform System
1.5 Market by Application
1.5.1 Global Lung Cancer Screening Software Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Medical Examination Institutions
1.5.4 Public Health Screening
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Screening Software Market Perspective (2021–2032)
2.2 Global Lung Cancer Screening Software Growth Trends by Region
2.2.1 Global Lung Cancer Screening Software Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Lung Cancer Screening Software Historic Market Size by Region (2021–2026)
2.2.3 Lung Cancer Screening Software Forecasted Market Size by Region (2027–2032)
2.3 Lung Cancer Screening Software Market Dynamics
2.3.1 Lung Cancer Screening Software Industry Trends
2.3.2 Lung Cancer Screening Software Market Drivers
2.3.3 Lung Cancer Screening Software Market Challenges
2.3.4 Lung Cancer Screening Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Screening Software Players by Revenue
3.1.1 Global Top Lung Cancer Screening Software Players by Revenue (2021–2026)
3.1.2 Global Lung Cancer Screening Software Revenue Market Share by Players (2021–2026)
3.2 Global Top Lung Cancer Screening Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Lung Cancer Screening Software Revenue
3.4 Global Lung Cancer Screening Software Market Concentration Ratio
3.4.1 Global Lung Cancer Screening Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Screening Software Revenue in 2025
3.5 Global Key Players of Lung Cancer Screening Software Head Offices and Areas Served
3.6 Global Key Players of Lung Cancer Screening Software, Products and Applications
3.7 Global Key Players of Lung Cancer Screening Software, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Lung Cancer Screening Software Breakdown Data by Type
4.1 Global Lung Cancer Screening Software Historic Market Size by Type (2021–2026)
4.2 Global Lung Cancer Screening Software Forecasted Market Size by Type (2027–2032)
5 Lung Cancer Screening Software Breakdown Data by Application
5.1 Global Lung Cancer Screening Software Historic Market Size by Application (2021–2026)
5.2 Global Lung Cancer Screening Software Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Lung Cancer Screening Software Market Size (2021–2032)
6.2 North America Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Lung Cancer Screening Software Market Size by Country (2021–2026)
6.4 North America Lung Cancer Screening Software Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Screening Software Market Size (2021–2032)
7.2 Europe Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Lung Cancer Screening Software Market Size by Country (2021–2026)
7.4 Europe Lung Cancer Screening Software Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Screening Software Market Size (2021–2032)
8.2 Asia-Pacific Lung Cancer Screening Software Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2021–2026)
8.4 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Lung Cancer Screening Software Market Size (2021–2032)
9.2 Latin America Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Lung Cancer Screening Software Market Size by Country (2021–2026)
9.4 Latin America Lung Cancer Screening Software Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Screening Software Market Size (2021–2032)
10.2 Middle East & Africa Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2021–2026)
10.4 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthineers
11.1.1 Siemens Healthineers Company Details
11.1.2 Siemens Healthineers Business Overview
11.1.3 Siemens Healthineers Lung Cancer Screening Software Introduction
11.1.4 Siemens Healthineers Revenue in Lung Cancer Screening Software Business (2021–2026)
11.1.5 Siemens Healthineers Recent Development
11.2 GE HealthCare
11.2.1 GE HealthCare Company Details
11.2.2 GE HealthCare Business Overview
11.2.3 GE HealthCare Lung Cancer Screening Software Introduction
11.2.4 GE HealthCare Revenue in Lung Cancer Screening Software Business (2021–2026)
11.2.5 GE HealthCare Recent Development
11.3 Philips Healthcare
11.3.1 Philips Healthcare Company Details
11.3.2 Philips Healthcare Business Overview
11.3.3 Philips Healthcare Lung Cancer Screening Software Introduction
11.3.4 Philips Healthcare Revenue in Lung Cancer Screening Software Business (2021–2026)
11.3.5 Philips Healthcare Recent Development
11.4 Canon Medical Systems
11.4.1 Canon Medical Systems Company Details
11.4.2 Canon Medical Systems Business Overview
11.4.3 Canon Medical Systems Lung Cancer Screening Software Introduction
11.4.4 Canon Medical Systems Revenue in Lung Cancer Screening Software Business (2021–2026)
11.4.5 Canon Medical Systems Recent Development
11.5 United Imaging Healthcare
11.5.1 United Imaging Healthcare Company Details
11.5.2 United Imaging Healthcare Business Overview
11.5.3 United Imaging Healthcare Lung Cancer Screening Software Introduction
11.5.4 United Imaging Healthcare Revenue in Lung Cancer Screening Software Business (2021–2026)
11.5.5 United Imaging Healthcare Recent Development
11.6 InferVision
11.6.1 InferVision Company Details
11.6.2 InferVision Business Overview
11.6.3 InferVision Lung Cancer Screening Software Introduction
11.6.4 InferVision Revenue in Lung Cancer Screening Software Business (2021–2026)
11.6.5 InferVision Recent Development
11.7 Airdoc
11.7.1 Airdoc Company Details
11.7.2 Airdoc Business Overview
11.7.3 Airdoc Lung Cancer Screening Software Introduction
11.7.4 Airdoc Revenue in Lung Cancer Screening Software Business (2021–2026)
11.7.5 Airdoc Recent Development
11.8 VUNO
11.8.1 VUNO Company Details
11.8.2 VUNO Business Overview
11.8.3 VUNO Lung Cancer Screening Software Introduction
11.8.4 VUNO Revenue in Lung Cancer Screening Software Business (2021–2026)
11.8.5 VUNO Recent Development
11.9 Lunit
11.9.1 Lunit Company Details
11.9.2 Lunit Business Overview
11.9.3 Lunit Lung Cancer Screening Software Introduction
11.9.4 Lunit Revenue in Lung Cancer Screening Software Business (2021–2026)
11.9.5 Lunit Recent Development
11.10 Qure.ai
11.10.1 Qure.ai Company Details
11.10.2 Qure.ai Business Overview
11.10.3 Qure.ai Lung Cancer Screening Software Introduction
11.10.4 Qure.ai Revenue in Lung Cancer Screening Software Business (2021–2026)
11.10.5 Qure.ai Recent Development
11.11 Riverain Technologies
11.11.1 Riverain Technologies Company Details
11.11.2 Riverain Technologies Business Overview
11.11.3 Riverain Technologies Lung Cancer Screening Software Introduction
11.11.4 Riverain Technologies Revenue in Lung Cancer Screening Software Business (2021–2026)
11.11.5 Riverain Technologies Recent Development
11.12 Zebra Medical Vision
11.12.1 Zebra Medical Vision Company Details
11.12.2 Zebra Medical Vision Business Overview
11.12.3 Zebra Medical Vision Lung Cancer Screening Software Introduction
11.12.4 Zebra Medical Vision Revenue in Lung Cancer Screening Software Business (2021–2026)
11.12.5 Zebra Medical Vision Recent Development
11.13 Arterys
11.13.1 Arterys Company Details
11.13.2 Arterys Business Overview
11.13.3 Arterys Lung Cancer Screening Software Introduction
11.13.4 Arterys Revenue in Lung Cancer Screening Software Business (2021–2026)
11.13.5 Arterys Recent Development
11.14 Deepwise
11.14.1 Deepwise Company Details
11.14.2 Deepwise Business Overview
11.14.3 Deepwise Lung Cancer Screening Software Introduction
11.14.4 Deepwise Revenue in Lung Cancer Screening Software Business (2021–2026)
11.14.5 Deepwise Recent Development
11.15 EverFortune AI
11.15.1 EverFortune AI Company Details
11.15.2 EverFortune AI Business Overview
11.15.3 EverFortune AI Lung Cancer Screening Software Introduction
11.15.4 EverFortune AI Revenue in Lung Cancer Screening Software Business (2021–2026)
11.15.5 EverFortune AI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Lung Cancer Screening Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Cloud-Based
Table 3. Key Players of Web-Based
Table 4. Global Lung Cancer Screening Software Market Size Growth Rate by Screening Technologies (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Nodule Detection
Table 6. Key Players of Nodule Analysis
Table 7. Key Players of Full-Process Screening
Table 8. Key Players of Predictive Assessment
Table 9. Global Lung Cancer Screening Software Market Size Growth Rate by System Integration Level (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Standalone AI Software
Table 11. Key Players of PACS/RIS Integrated Plugin
Table 12. Key Players of Built-in Solution for Imaging Equipment
Table 13. Key Players of Regional Screening Platform System
Table 14. Global Lung Cancer Screening Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Lung Cancer Screening Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Lung Cancer Screening Software Market Size by Region (US$ Million), 2021–2026
Table 17. Global Lung Cancer Screening Software Market Share by Region (2021–2026)
Table 18. Global Lung Cancer Screening Software Forecasted Market Size by Region (US$ Million), 2027–2032
Table 19. Global Lung Cancer Screening Software Market Share by Region (2027–2032)
Table 20. Lung Cancer Screening Software Market Trends
Table 21. Lung Cancer Screening Software Market Drivers
Table 22. Lung Cancer Screening Software Market Challenges
Table 23. Lung Cancer Screening Software Market Restraints
Table 24. Global Lung Cancer Screening Software Revenue by Players (US$ Million), 2021–2026
Table 25. Global Lung Cancer Screening Software Market Share by Players (2021–2026)
Table 26. Global Top Lung Cancer Screening Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lung Cancer Screening Software Revenue, 2025
Table 27. Ranking of Global Top Lung Cancer Screening Software Companies by Revenue (US$ Million) in 2025
Table 28. Global 5 Largest Players Market Share by Lung Cancer Screening Software Revenue (CR5 and HHI), 2021–2026
Table 29. Global Key Players of Lung Cancer Screening Software, Headquarters and Area Served
Table 30. Global Key Players of Lung Cancer Screening Software, Products and Applications
Table 31. Global Key Players of Lung Cancer Screening Software, Date of General Availability (GA)
Table 32. Mergers and Acquisitions, Expansion Plans
Table 33. Global Lung Cancer Screening Software Market Size by Type (US$ Million), 2021–2026
Table 34. Global Lung Cancer Screening Software Revenue Market Share by Type (2021–2026)
Table 35. Global Lung Cancer Screening Software Forecasted Market Size by Type (US$ Million), 2027–2032
Table 36. Global Lung Cancer Screening Software Revenue Market Share by Type (2027–2032)
Table 37. Global Lung Cancer Screening Software Market Size by Application (US$ Million), 2021–2026
Table 38. Global Lung Cancer Screening Software Revenue Market Share by Application (2021–2026)
Table 39. Global Lung Cancer Screening Software Forecasted Market Size by Application (US$ Million), 2027–2032
Table 40. Global Lung Cancer Screening Software Revenue Market Share by Application (2027–2032)
Table 41. North America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. North America Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026
Table 43. North America Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032
Table 44. Europe Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Europe Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026
Table 46. Europe Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032
Table 47. Asia-Pacific Lung Cancer Screening Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 48. Asia-Pacific Lung Cancer Screening Software Market Size by Region (US$ Million), 2021–2026
Table 49. Asia-Pacific Lung Cancer Screening Software Market Size by Region (US$ Million), 2027–2032
Table 50. Latin America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Latin America Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026
Table 52. Latin America Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032
Table 53. Middle East & Africa Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Middle East & Africa Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026
Table 55. Middle East & Africa Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032
Table 56. Siemens Healthineers Company Details
Table 57. Siemens Healthineers Business Overview
Table 58. Siemens Healthineers Lung Cancer Screening Software Product
Table 59. Siemens Healthineers Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 60. Siemens Healthineers Recent Development
Table 61. GE HealthCare Company Details
Table 62. GE HealthCare Business Overview
Table 63. GE HealthCare Lung Cancer Screening Software Product
Table 64. GE HealthCare Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 65. GE HealthCare Recent Development
Table 66. Philips Healthcare Company Details
Table 67. Philips Healthcare Business Overview
Table 68. Philips Healthcare Lung Cancer Screening Software Product
Table 69. Philips Healthcare Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 70. Philips Healthcare Recent Development
Table 71. Canon Medical Systems Company Details
Table 72. Canon Medical Systems Business Overview
Table 73. Canon Medical Systems Lung Cancer Screening Software Product
Table 74. Canon Medical Systems Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 75. Canon Medical Systems Recent Development
Table 76. United Imaging Healthcare Company Details
Table 77. United Imaging Healthcare Business Overview
Table 78. United Imaging Healthcare Lung Cancer Screening Software Product
Table 79. United Imaging Healthcare Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 80. United Imaging Healthcare Recent Development
Table 81. InferVision Company Details
Table 82. InferVision Business Overview
Table 83. InferVision Lung Cancer Screening Software Product
Table 84. InferVision Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 85. InferVision Recent Development
Table 86. Airdoc Company Details
Table 87. Airdoc Business Overview
Table 88. Airdoc Lung Cancer Screening Software Product
Table 89. Airdoc Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 90. Airdoc Recent Development
Table 91. VUNO Company Details
Table 92. VUNO Business Overview
Table 93. VUNO Lung Cancer Screening Software Product
Table 94. VUNO Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 95. VUNO Recent Development
Table 96. Lunit Company Details
Table 97. Lunit Business Overview
Table 98. Lunit Lung Cancer Screening Software Product
Table 99. Lunit Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 100. Lunit Recent Development
Table 101. Qure.ai Company Details
Table 102. Qure.ai Business Overview
Table 103. Qure.ai Lung Cancer Screening Software Product
Table 104. Qure.ai Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 105. Qure.ai Recent Development
Table 106. Riverain Technologies Company Details
Table 107. Riverain Technologies Business Overview
Table 108. Riverain Technologies Lung Cancer Screening Software Product
Table 109. Riverain Technologies Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 110. Riverain Technologies Recent Development
Table 111. Zebra Medical Vision Company Details
Table 112. Zebra Medical Vision Business Overview
Table 113. Zebra Medical Vision Lung Cancer Screening Software Product
Table 114. Zebra Medical Vision Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 115. Zebra Medical Vision Recent Development
Table 116. Arterys Company Details
Table 117. Arterys Business Overview
Table 118. Arterys Lung Cancer Screening Software Product
Table 119. Arterys Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 120. Arterys Recent Development
Table 121. Deepwise Company Details
Table 122. Deepwise Business Overview
Table 123. Deepwise Lung Cancer Screening Software Product
Table 124. Deepwise Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 125. Deepwise Recent Development
Table 126. EverFortune AI Company Details
Table 127. EverFortune AI Business Overview
Table 128. EverFortune AI Lung Cancer Screening Software Product
Table 129. EverFortune AI Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026
Table 130. EverFortune AI Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Lung Cancer Screening Software Picture
Figure 2. Global Lung Cancer Screening Software Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Lung Cancer Screening Software Market Share by Type: 2025 vs 2032
Figure 4. Cloud-Based Features
Figure 5. Web-Based Features
Figure 6. Global Lung Cancer Screening Software Market Size Comparison by Screening Technologies (US$ Million), 2021–2032
Figure 7. Nodule Detection Features
Figure 8. Nodule Analysis Features
Figure 9. Full-Process Screening Features
Figure 10. Predictive Assessment Features
Figure 11. Global Lung Cancer Screening Software Market Size Comparison by System Integration Level (US$ Million), 2021–2032
Figure 12. Standalone AI Software Features
Figure 13. PACS/RIS Integrated Plugin Features
Figure 14. Built-in Solution for Imaging Equipment Features
Figure 15. Regional Screening Platform System Features
Figure 16. Global Lung Cancer Screening Software Market Size by Application (US$ Million), 2021–2032
Figure 17. Global Lung Cancer Screening Software Market Share by Application: 2025 vs 2032
Figure 18. Hospitals Case Studies
Figure 19. Medical Examination Institutions Case Studies
Figure 20. Public Health Screening Case Studies
Figure 21. Others Case Studies
Figure 22. Lung Cancer Screening Software Report Years Considered
Figure 23. Global Lung Cancer Screening Software Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 24. Global Lung Cancer Screening Software Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Lung Cancer Screening Software Market Share by Region: 2025 vs 2032
Figure 26. Global Lung Cancer Screening Software Market Share by Players in 2025
Figure 27. Global Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Lung Cancer Screening Software Revenue in 2025
Figure 29. North America Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. North America Lung Cancer Screening Software Market Share by Country (2021–2032)
Figure 31. United States Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Canada Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Lung Cancer Screening Software Market Share by Country (2021–2032)
Figure 35. Germany Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. France Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. U.K. Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Italy Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Russia Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Ireland Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Lung Cancer Screening Software Market Share by Region (2021–2032)
Figure 43. China Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Japan Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. South Korea Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Southeast Asia Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. India Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Australia & New Zealand Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Lung Cancer Screening Software Market Share by Country (2021–2032)
Figure 51. Mexico Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Brazil Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Lung Cancer Screening Software Market Share by Country (2021–2032)
Figure 55. Israel Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Saudi Arabia Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. UAE Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Siemens Healthineers Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 59. GE HealthCare Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 60. Philips Healthcare Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 61. Canon Medical Systems Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 62. United Imaging Healthcare Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 63. InferVision Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 64. Airdoc Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 65. VUNO Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 66. Lunit Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 67. Qure.ai Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 68. Riverain Technologies Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 69. Zebra Medical Vision Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 70. Arterys Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 71. Deepwise Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 72. EverFortune AI Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Lung Cancer Screening Software in 2032?
The global market size of Lung Cancer Screening Software in 2032 was 5434 Million USD.
Which region is expected to have the highest market share?
Which companies rank high in the global Lung Cancer Screening Software market?
What was the global market size of Lung Cancer Screening Software in 2026?
What is the annual compound growth rate of the global Lung Cancer Screening Software market size from 2026 to 2032?
Related Reports
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-14
Pages: 132
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 117
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published Date: 2026-01-14
Pages: 98
USD 4250.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 126
USD 4900.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 77
USD 4250.00
(Single User License)
Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 100
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2025
The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 74
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 92
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 79
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-14
Pages: 132
USD 4900.00 (Single User License)Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 117
USD 3950.00 (Single User License)Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Published: 2026-01-14
Pages: 98
USD 4250.00 (Single User License)Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 126
USD 4900.00 (Single User License)Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 77
USD 4250.00 (Single User License)Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 100
USD 3950.00 (Single User License)Global Lung Cancer Screening Software Market Research Report 2025
The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 74
USD 2900.00 (Single User License)Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 92
USD 3950.00 (Single User License)Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 79
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now